We selected HRAS oncogene because a significant fraction of metastatic breast cancers demonstrate HRAS amplification based on data extracted from metastatic breast cancer sequencing project in cBioportal (Fig. 4A; ref. 13). The gene discussed is HRAS; the disease is breast carcinoma.